IceCure Reports Positive Results In Tumor-Freezing Breast Cancer Trial
IceCure's ProSense is a liquid-nitrogen-based cryoablation system used in the treatment of patients with T1 invasive breast cancer.
May 09, 2021
Israeli Firm Freezing Cancer Tumors Raises $6M In Equity Offering
IceCure Medical's cryoablation technology treats benign and malignant tumors by freezing them and turning them into ice balls.
August 09, 2020